Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

University of Alberta

$135,000.00

Oral Sildenafil therapy for mild chronic obstructive pulmonary disease: targeted therapy for pulmonary vascular remodeling to improve dyspnea and exercise tolerance.

FY 2020-21

Summary
Lay Abstract: The goal of this project is to examine how lung blood vessel dysfunction contributes to exercise intolerance in patients with chronic obstructive pulmonary disease (COPD). COPD is a condition characterized by airway obstruction and is currently the 4th leading cause of death in Canada. Patients with COPD experience significant shortness of breath, which has been shown to reduce quality of life and physical activity, and increase risk of mortality. Much work has examined breathlessness in moderate and severe COPD, but the reasons for breathlessness in patients with mild COPD are not well understood. Mild COPD patients show an exaggerated breathing response to exercise. Recent work suggests that the increased breathing response during exercise in mild COPD is because of poor matching of regional lung air and blood flow. Researchers have proposed that this imbalance is because of dysfunction of blood vessels in the lungs. Recently the Stickland Laboratory has shown that inhaled nitric oxide dilates blood vessels in the lungs, and therefore reduces shortness of breath, the breathing response to exercise, and improves exercise capacity in mild COPD. These findings suggest that dysfunction of blood vessels in the lungs is an important contributor to exercise intolerance in mild COPD. Building on this previous work, we aim to determine whether oral sildenafil (a pill given clinical to improve blood vessel function in the lungs) improves exercise tolerance in mild COPD patients.
Program
CIHR Fellowship
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
440900
Name
Beaudry Rhys I
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Health Research Training A - Post-PhD (HTA)
Projecttitle
Oral Sildenafil therapy for mild chronic obstructive pulmonary disease: targeted therapy for pulmonary vascular remodeling to improve dyspnea and exercise tolerance.
Programtype2
Fellowship Programs
Orgnameinp2
University of Alberta
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Chronic Obstructive Pulmonary Disease; Clinical Intervention; Dyspnea; Pulmonary Vascular Remodeling; Sildenafil; Ventilation/Perfusion Matching
Abstract
Lay Abstract: The goal of this project is to examine how lung blood vessel dysfunction contributes to exercise intolerance in patients with chronic obstructive pulmonary disease (COPD). COPD is a condition characterized by airway obstruction and is currently the 4th leading cause of death in Canada. Patients with COPD experience significant shortness of breath, which has been shown to reduce quality of life and physical activity, and increase risk of mortality. Much work has examined breathlessness in moderate and severe COPD, but the reasons for breathlessness in patients with mild COPD are not well understood. Mild COPD patients show an exaggerated breathing response to exercise. Recent work suggests that the increased breathing response during exercise in mild COPD is because of poor matching of regional lung air and blood flow. Researchers have proposed that this imbalance is because of dysfunction of blood vessels in the lungs. Recently the Stickland Laboratory has shown that inhaled nitric oxide dilates blood vessels in the lungs, and therefore reduces shortness of breath, the breathing response to exercise, and improves exercise capacity in mild COPD. These findings suggest that dysfunction of blood vessels in the lungs is an important contributor to exercise intolerance in mild COPD. Building on this previous work, we aim to determine whether oral sildenafil (a pill given clinical to improve blood vessel function in the lungs) improves exercise tolerance in mild COPD patients.
Competitiondate
202012
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Beaudry, Rhys I
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~